Related Experiment Video
Updated: Jul 16, 2026

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
Endoscopic treatment of ulcer bleeding
Thomas O G Kovacs1, Dennis M Jensen
1CURE Digestive Diseases Research Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073-1003, USA. tkovacs@mednet.ucla.edu
Endoscopic hemostasis effectively treats high-risk upper gastrointestinal (UGI) bleeding from ulcers. Combination therapy and proton-pump inhibitors improve outcomes for major bleeding stigmata, reducing complications and costs.
Area of Science:
- Gastroenterology
- Endoscopy
- Internal Medicine
Background:
- Upper gastrointestinal (UGI) bleeding from ulcer disease is a common cause of morbidity and healthcare expenditure.
- Endoscopy is crucial for diagnosing UGI hemorrhage and identifying patients who benefit from intervention.
Purpose of the Study:
- To outline current recommendations for the endoscopic management of upper gastrointestinal ulcer bleeding.
- To identify high-risk patient subgroups and effective hemostatic strategies.
Main Methods:
- Review of endoscopic techniques and hemostatic devices for UGI bleeding.
- Emphasis on experienced endoscopists and large-channel therapeutic endoscopes.
- Recommendations for combination therapy (epinephrine injection plus thermal coagulation or endoclips) for major stigmata.
Main Results:
- Combination endoscopic hemostasis with epinephrine and thermal/clip devices, along with IV PPIs, is recommended for major stigmata (active bleeding, visible vessel, adherent clot).
- Patients with minor stigmata or clean-based ulcers do not benefit from endoscopic therapy and can be considered for early discharge.
- Effective hemostasis reduces rebleeding, transfusion needs, surgical intervention, and overall medical costs.
Conclusions:
- Endoscopic hemostasis is a vital tool in managing UGI ulcer bleeding.
- Targeted therapy for high-risk stigmata improves patient outcomes and reduces healthcare resource utilization.
- Experienced endoscopists are essential for successful management of UGI hemorrhage.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy